Follow
Petra Marešová
Title
Cited by
Cited by
Year
Economics aspects of ageing population
P Marešová, H Mohelská, K Kuča
Procedia economics and finance 23, 534-538, 2015
1052015
The potential of medical device industry in technological and economical context
P Maresova, M Penhaker, A Selamat, K Kuca
Therapeutics and clinical risk management, 1505-1514, 2015
742015
Alzheimers disease: cost cuts call for novel drugs development and national strategy.
P Marešová, B Klímová, K Kuča
Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a …, 2015
382015
Medical device development process, and associated risks and legislative aspects-systematic review
P Marešová, B Klimova, J Honegr, K Kuča, WNH Ibrahim, A Selamat
Frontiers in public health 8, 523190, 2020
322020
Deployment of cloud computing in small and medium size enterprises in the Czech republic
P Marešová, V Hálek
Technická univerzita v Liberci, 2014
272014
Ethical Questions Linked to Rare Diseases and Orphan Drugs–A Systematic Review
J Kacetl, P Marešová, R Maskuriy, A Selamat
Risk management and healthcare policy, 2125-2148, 2020
262020
Knowledge management in Czech enterprises
P Maresova
E & M EKONOMIE A MANAGEMENT 13 (1), 131-144, 2010
262010
Měření ve znalostním managementu-aplikace metody Cost Benefit Analysis
P Marešová
Gaudeamus, 2012
252012
Výzkum uplatnění znalostního managementu v českých podnicích
P Marešová
Technická univerzita v Liberci, 2010
252010
The economic burden of the care and treatment for people with Alzheimer’s disease: the outlook for the Czech Republic
P Marešová, V Zahálková
Neurological Sciences 37, 1917-1922, 2016
232016
Cost of treatment and care for people with Alzheimer’s disease: a meta-analysis
P Marešová, J Dolejs, H Mohelska, LK Bryan
Current Alzheimer Research 16 (14), 1245-1253, 2019
222019
A comprehensive view on evaluation of cluster initiatives
V Bureš, V Jašíková, T Otčenášková, K Kolerová, V Zubr, P Marešová
8th European Conference on Management Leadership and Governance ECMLG-12, 74-79, 2012
202012
Cooperation policy of rare diseases in the European Union
P Marešová, H Mohelská, K Kuča
Procedia-Social and Behavioral Sciences 171, 1302-1308, 2015
172015
Call for a uniform strategy of collecting Alzheimer’s disease costs: a review and meta-analysis
P Marešová, J Dolejš, K Kuca
Journal of Alzheimer's Disease 63 (1), 227-238, 2018
162018
Onset of mortality increase with age and age trajectories of mortality from all diseases in the four Nordic countries
J Dolejs, P Marešová
Clinical Interventions in Aging, 161-173, 2017
162017
University of Hradec Kralove: Hradec Kralove
P Jedlicka, P Marešová, I Soukal
Czech Republic 8, 196-205, 2018
152018
Complexity stage model of the medical device development based on economic evaluation—MedDee
P Marešová, L Peter, J Honegr, L Režný, M Penhaker, M Augustýnek, ...
Sustainability 12 (5), 1755, 2020
112020
Use effectiveness of medical devices: a case study on the deployment of ultrasonographic devices
M Augustýnek, D Laryš, J Kubíček, P Marešová, K Kuča
Therapeutic innovation & regulatory science 52 (4), 499-506, 2018
112018
Process cost management of Alzheimer’s disease
H Tomaskova, M Kopecky, P Maresova
Processes 7 (9), 582, 2019
102019
Effective evaluation of cloud computing investment: application of cost benefit method analysis
P Marešová, V Soběslav
Technická univerzita v Liberci, 2017
102017
The system can't perform the operation now. Try again later.
Articles 1–20